{
    "statements": [
        {
            "id": "moa.assertion:71",
            "description": "T315I mutant ABL1 in p210 BCR-ABL cells resulted in retained high levels of phosphotyrosine at increasing concentrations of inhibitor STI-571, whereas wildtype appropriately received inhibition.",
            "evidence_level": "moa.evidence_level:Preclinical",
            "proposition": "proposition:ReqWtqemZoVtMAGpxG5G6w3HLvlS8KvW",
            "variation_origin": "somatic",
            "variation_descriptor": "moa.variant:71",
            "therapy_descriptor": "moa.normalize.therapy:Imatinib",
            "disease_descriptor": "moa.normalize.disease:oncotree%3ACML",
            "method": "method:004",
            "supported_by": [
                "pmid:11423618"
            ],
            "type": "Statement"
        }
    ],
    "propositions": [
        {
            "id": "proposition:ReqWtqemZoVtMAGpxG5G6w3HLvlS8KvW",
            "type": "therapeutic_response_proposition",
            "predicate": "predicts_resistance_to",
            "subject": "ga4gh:VA.M3CbaYfwomLqvJbdK4w-W7V-zw7LdjGj",
            "object_qualifier": "ncit:C3174",
            "object": "rxcui:282388"
        }
    ],
    "variation_descriptors": [
        {
            "id": "moa.variant:71",
            "type": "VariationDescriptor",
            "label": "ABL1 p.T315I (Missense)",
            "extensions": [
                {
                    "type": "Extension",
                    "name": "moa_representative_coordinate",
                    "value": {
                        "chromosome": "9",
                        "start_position": "133747580.0",
                        "end_position": "133747580.0",
                        "reference_allele": "C",
                        "alternate_allele": "T",
                        "cdna_change": "c.944C>T",
                        "protein_change": "p.T315I",
                        "exon": "5.0"
                    }
                }
            ],
            "variation_id": "ga4gh:VA.M3CbaYfwomLqvJbdK4w-W7V-zw7LdjGj",
            "variation": {
                "_id": "ga4gh:VA.M3CbaYfwomLqvJbdK4w-W7V-zw7LdjGj",
                "type": "Allele",
                "location": {
                    "_id": "ga4gh:VSL.JkBiKTd3Kq-l0ZSOzCOJ1i60mh03hXb5",
                    "type": "SequenceLocation",
                    "sequence_id": "ga4gh:SQ.dmFigTG-0fY6I54swb7PoDuxCeT6O3Wg",
                    "interval": {
                        "type": "SequenceInterval",
                        "start": {
                            "type": "Number",
                            "value": 314
                        },
                        "end": {
                            "type": "Number",
                            "value": 315
                        }
                    }
                },
                "state": {
                    "type": "LiteralSequenceExpression",
                    "sequence": "I"
                }
            },
            "gene_context": "moa.normalize.gene:ABL1",
            "vrs_ref_allele_seq": "T"
        }
    ],
    "gene_descriptors": [
        {
            "id": "moa.normalize.gene:ABL1",
            "type": "GeneDescriptor",
            "label": "ABL1",
            "gene_id": "hgnc:76"
        }
    ],
    "therapy_descriptors": [
        {
            "id": "moa.normalize.therapy:Imatinib",
            "type": "TherapyDescriptor",
            "label": "Imatinib",
            "therapy_id": "rxcui:282388"
        }
    ],
    "disease_descriptors": [
        {
            "id": "moa.normalize.disease:oncotree%3ACML",
            "type": "DiseaseDescriptor",
            "label": "Chronic Myelogenous Leukemia",
            "disease_id": "ncit:C3174"
        }
    ],
    "methods": [
        {
            "id": "method:004",
            "label": "Clinical interpretation of integrative molecular profiles to guide precision cancer medicine",
            "url": "https://www.biorxiv.org/content/10.1101/2020.09.22.308833v1",
            "version": {
                "year": 2020,
                "month": 9,
                "day": 22
            },
            "authors": "Reardon, B., Moore, N.D., Moore, N. et al.",
            "type": "Method"
        }
    ],
    "documents": [
        {
            "id": "pmid:11423618",
            "label": "Gorre, Mercedes E., et al. \"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.\" Science 293.5531 (2001): 876-880.",
            "xrefs": [
                "doi:10.1126/science.1062538"
            ],
            "type": "Document"
        }
    ]
}